MiniMed Insulin Pump Therapy
MiniMed™ 780G Insulin Pump System
Approved for insulin-requiring Type 1 (ages 7+) and Type 2 (ages 18+) diabetes, the MiniMed™ 780G insulin delivery system uses Meal Detection™ technology* to automatically adjust insulin every five minutes, helping keep glucose levels in range—even when life gets busy.
- Anticipates — Looks ahead at where your glucose is going using real-time data and past patterns to estimate how much insulin you’ll need.
- Adjusts — Fine-tunes insulin delivery throughout the day to help prevent highs and lows.
- Corrects — Automatically helps bring down highs, even if carbs were undercounted or a meal dose was missed.¶
Sensor options: The system works with multiple sensors, including the new Instinct sensor, made by Abbott, and the Guardian 4 sensor.
Mealtime dosing: The bolus calculator does the math and tracks active insulin to help prevent stacking and lows.
More stable blood sugar: Automatic basal adjustments help reduce highs and lows day and night. ¶
FREQUENTLY ASKED QUESTIONS
The MiniMed 780G system is approved for people with Type 1 diabetes ages 7 and older, as well as for adults with Type 2 diabetes who are insulin-dependent. The CGM component of the system follows these same indications. The new Instinct sensor, made by Abbott, is currently approved only for people with Type 1 diabetes, while the Guardian 4 sensor is approved for people with either Type 1 or Type 2 diabetes.
The MiniMed 780G insulin pump system works with both the Instinct and Guardian 4 sensors. Depending on the sensor you select, you may need to update your pump software, but the latest MiniMed 780G software will work with all options.
To see whether your smartphone or your Apple® Watch is compatible, please check the MiniMed compatibility tool.
The MiniMed™ Mobile app lets you view your pump and CGM information on your smartphone or compatible Apple Watch, making it easier to track glucose trends and receive alerts if you’re heading high or low. The app also supports automatic uploads of pump and sensor data to CareLink™ software. The MiniMed 780G system is the only MiniMed system with a mobile app that works with select Apple Watch models. An iPhone is required to use the Apple Watch extension. iPhone and Apple Watch not included with the MiniMed 780G system.
Yes, many insurance plans (including Medicaid and Medicare) cover insulin pump therapy and continuous glucose monitoring that integrates for those who qualify. Once you’ve completed our online application, we will work with you, your healthcare provider, and insurance company to help you get the insulin pump and supplies you need. If you have any questions, please reach out to our Diabetes Care team at DCA@myehcs.com.
The MiniMed™ 780G system significantly reduces the need for fingersticks, but does not eliminate them entirely. The Instinct sensor and Guardian 4 sensor do not require fingersticks for calibration or for making treatment decisions when using SmartGuard™ technology<sup>†</sup>. In most situations, you won’t need to check your blood glucose. However, for safety and to ensure the SmartGuard algorithm performs at its best, there are certain situations where the pump may still request a fingerstick reading.
Click this link to apply for a Medtronic insulin pump. EHCS will pair you with a Diabetes Care Advisor to help you through the process. From insurance approval to future reorders, our team of DCAs is your guide to better diabetes control.
Most insulin pumps have a standard 4-year replacement warranty. If you’re interested in upgrading your insulin pump, please reach out to our team of Diabetes Care Advisors at DCA@myehcs.com. They will know your pump’s warranty time, upgrade timeframe, and criteria for upgrading.
EHCS is an authorized distributor of MiniMed insulin pump therapy. We strive to provide you with quality products and multiple options.
Footnotes
† Refers to auto correct, which provides bolus assistance. Can deliver all correction doses automatically without user interaction, feature can be turned on and off.
‡ Taking a bolus 15 – 20 minutes before a meal helps to keep blood sugar levels under control after eating.
§ Glucose targets should be chosen following a consultation with your healthcare provider.
◊ Due to inherent real-world study limitations, caution is advised when attempting to extrapolate these results to new patients. There could be significant differences. Overnight period: 3:00 AM- 6:00 AM. Number of users with ≥10 days of sensor glucose data; Optimal settings are glucose target at 100 mg/dL (5.5 mmol/L) and Active Insulin Time (AIT) at 2 hours and used >95% of the time.
¶ Refers to SmartGuard™ technology. Individual results may vary.
References
1. Adults, T1 and parents of children with T1 diabetes < 18 years were surveyed
2. Individual results may vary.
3. dQ&A US Patient Voice Q2 2025.p. 77. N=215
4. Data on file, Abbott Diabetes Care, Inc.
5. McVean, et al. 972-P: Hyperglycemia from Real-World Dawn Phenomenon Is Nearly Eliminated with the MiniMed 780G System (MM780G). Diabetes 14 June 2024; 73 (Supplement_1): 972–P. https://doi.org/10.2337/db24-972-P
Important Safety Information: MiniMed™ 780G system with SmartGuard™ technology with Instinct sensor, Simplera Sync™ sensor, and Guardian™ 4 sensor
The MiniMed™ 780G system is intended for the continuous delivery of basal insulin at selectable rates and the administration of insulin boluses at selectable rates for the management of type 1 diabetes mellitus in persons 7 years of age and older using the Instinct, Simplera Sync™ or Guardian™ 4 sensor, and of type 2 diabetes mellitus in persons 18 years of age and older requiring insulin using the Simplera Sync™ or Guardian™ 4 sensor.
The MiniMed™ 780G System includes SmartGuard™ technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values. The system is intended for use with connected sensors, including the Simplera Sync™ and Guardian™ 4 sensors and integrated continuous glucose monitors, including the Instinct sensor, each of which has different wear-time, form factor, insertion site, and other distinguishing characteristics that relate to sensor performance. Consult the appropriate sensor user guide when using the system. Discuss treatment decisions with your HCP.
WARNING: Do not use the MiniMed™ 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 780G system.
WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard™ feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a blood glucose (BG) meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.
Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women, persons with type 2 diabetes using the Instinct sensor, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including accessories and additional important safety information concerning indications, contraindications, warnings and precautions associated with the system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information and the appropriate user guide at https://www.medtronicdiabetes.com/download-library.
©2025 Medtronic. MiniMed and MiniMed logo are trademarks of Medtronic MiniMed, Inc. The sensor shape and appearance, Abbott, and “a” logo are marks and/or designs of the Abbott group of companies in various territories and used under license. Sensor image ©2025 Abbott. ™*Third–party brands are trademarks of their respective owners.